Is Medtronic PLC (MDT) overvalued? · P/E 21, rev $36.36B
Medtronic PLC (MDT) is a medical devices company listed on US.
This page asks whether Medtronic PLC (MDT) looks expensive on cached numbers — not a short thesis.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MDT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MDT stock page for the full model, not this heading.
Not investment advice.